000 01391 a2200385 4500
005 20250515035307.0
264 0 _c20070516
008 200705s 0 0 eng d
022 _a0300-8428
024 7 _a10.1007/s00395-006-0613-4
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aGonon, Adrian T
245 0 0 _aCardioprotection mediated by rosiglitazone, a peroxisome proliferator-activated receptor gamma ligand, in relation to nitric oxide.
_h[electronic resource]
260 _bBasic research in cardiology
_cJan 2007
300 _a80-9 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAnimals
650 0 4 _aBlotting, Western
650 0 4 _aHypoglycemic Agents
_xpharmacology
650 0 4 _aIn Vitro Techniques
650 0 4 _aMice
650 0 4 _aMice, Inbred C57BL
650 0 4 _aMice, Knockout
650 0 4 _aNitric Oxide
_xpharmacology
650 0 4 _aNitric Oxide Synthase Type III
_xmetabolism
650 0 4 _aPPAR gamma
_xagonists
650 0 4 _aRosiglitazone
650 0 4 _aThiazolidinediones
_xpharmacology
700 1 _aBulhak, Aliaksandr
700 1 _aLabruto, Fausto
700 1 _aSjöquist, Per-Ove
700 1 _aPernow, John
773 0 _tBasic research in cardiology
_gvol. 102
_gno. 1
_gp. 80-9
856 4 0 _uhttps://doi.org/10.1007/s00395-006-0613-4
_zAvailable from publisher's website
999 _c16488161
_d16488161